Document is current
Any future updates will be listed below
-
Authors
Bissen-Miyajima, Hiroko https://orcid.org/0000-0003-0417-2363
Ota, Yuka
Minami, Keiichiro https://orcid.org/0000-0002-9799-8342
Taira, Yoko
Takemura, Ryo
-
Funding
Funding for this research was provided by:
Johnson and Johnson
- License Information
-
More Information
Article History
Received: 13 August 2024
Accepted: 6 September 2024
First Online: 21 September 2024
Declarations
:
: Hiroko Bissen-Miyajima reports grant, consultant, and speaker honorarium from Alcon and Johnson & Johnson Surgical Vision, consultant from BVI and Zeiss, speaker honorarium from BVI and Hoya. Hiroko Bissen-Miyajima is an Editorial Board member of<i> Ophthalmology and Therapy</i>. Hiroko Bissen-Miyajima was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Yuka Ota reports speaker honorarium from Johnson & Johnson Surgical Vision. Keiichiro Minami reports Patent pending from Tomey. Yoko Taira and Ryo Takemura declare that they have no competing interests.
: This investigator-initiated study was approved by the Certified Review Board, Hattori Clinic (CRB3180027 - approval ref 731ET), and registered in the Japan Registry for Clinical Research (identifier jRCTs032200218). The study was conducted in accordance with the tenets of the Declaration of Helsinki and the Clinical Trials Act of Japan (Act No. 16, 2017). Written informed consent was obtained from all participants after explaining the study protocol.
